Abstract:

Obstructive sleep apnea-hypopnea syndrome (OSAHS) is a disease marked by apnea, hypopnea, decreased oxygen saturation, and disordered sleep structure, which is a major risk for cardiovascular disease. Recent studies have found that OSAHS patients have an increased risk of hypertension, coronary atherosclerotic heart disease, insulin resistance, type 2 diabetes, metabolic syndrome, non-alcoholic fatty liver disease, etc. And these patients have a high prevalence of obvious glucolipid metabolism disorder (GMD) , which plays an important role in cardiovascular morbidity and mortality in OSAHS. We reviewed the latest advances in the association of GMD and OSAHS, and the potential pathogenesis of OSAHS-induced GMD and insulin resistance, aiming at providing new ideas for clinical treatment of GMD in OSAHS.

Key words: Sleep apnea, obstructive, OSAHS, Glucose metabolism, Lipid metabolism, Insulin resistance, Cardiovascular diseases, Review

摘要：

阻塞性睡眠呼吸暂停低通气综合征（OSAHS）是以呼吸暂停、低通气、血氧饱和度下降及睡眠结构紊乱为特征的一种疾病，是心血管疾病的严重危险因素。近年来研究发现，OSAHS患者合并高血压、冠状动脉粥样硬化性心脏病、胰岛素抵抗、2型糖尿病、代谢综合征、非酒精性脂肪肝等疾病的发病率增加。诸多研究显示，OSAHS患者常存在明显的糖脂代谢紊乱，并在心血管疾病的发病率、死亡率中扮演着重要角色。因此，本文从OSAHS与糖脂代谢的关系入手，从病因学层面，就OSAHS引起糖脂代谢紊乱及胰岛素抵抗的机制作一综述，以期为临床治疗提供新的思路。

关键词: 睡眠呼吸暂停, 阻塞性, 阻塞性睡眠呼吸暂停低通气综合征, 糖代谢, 脂代谢, 胰岛素抵抗, 心血管疾病, 综述